Aspirus Wausau Hospital | |
333 Pine Ridge Blvd, Wausau, Wisconsin 54401 | |
(715) 847-2121 | |
Name | Aspirus Wausau Hospital |
---|---|
Type | Acute Care Hospital |
Location | 333 Pine Ridge Blvd, Wausau, Wisconsin |
Ownership | Proprietary |
Emergency Services | Yes |
Medicare ID (CCN) | 520030 |
NPI Number | 1548449861 |
Organization Name | ASPIRUS INC |
Address | 425 Pine Ridge Blvd, Wausau, WI 54401 |
Hospital Type | General Acute Care Hospital |
Phone Number | 715-847-2121 |
News Archive
Researchers at Lund University have unexpectedly discovered that an old cancer drug can be used to prevent rejection of transplanted tissue. The researchers now have high hopes that their discovery could lead to new treatments for both transplant patients and patients with autoimmune diseases.
A group of researchers at the Institute for Research in Immunology and Cancer (IRIC) of Université de Montréal discovered a promising new approach to treating leukemia by disarming a gene that is responsible for tumor progression.
A new and comprehensive study by investigators at the Celiac Disease Center at Columbia University Medical Center has found that celiac patients are at no increased risk for dementia before or after their diagnosis of celiac disease.
The latest issue of Biological Psychiatry presents the results of three studies implicating metabotropic glutamate receptor 2 (mGluR2) as a new molecular target for the treatment of addiction.
"An HIV/AIDS report by advocacy organizations in Uganda indicates that new transmissions are on the rise amidst troubling trends of increasing prevalence and incidence," Uganda's New Vision reports.
› Verified 3 days ago
NPI Number | 1558363986 |
Organization Name | ASPIRUS WAUSAU HOSPITAL, INC |
Address | 333 Pine Ridge Blvd, Wausau, WI 54401 |
Hospital Type | General Acute Care Hospital |
Phone Number | 715-847-2121 |
News Archive
Researchers at Lund University have unexpectedly discovered that an old cancer drug can be used to prevent rejection of transplanted tissue. The researchers now have high hopes that their discovery could lead to new treatments for both transplant patients and patients with autoimmune diseases.
A group of researchers at the Institute for Research in Immunology and Cancer (IRIC) of Université de Montréal discovered a promising new approach to treating leukemia by disarming a gene that is responsible for tumor progression.
A new and comprehensive study by investigators at the Celiac Disease Center at Columbia University Medical Center has found that celiac patients are at no increased risk for dementia before or after their diagnosis of celiac disease.
The latest issue of Biological Psychiatry presents the results of three studies implicating metabotropic glutamate receptor 2 (mGluR2) as a new molecular target for the treatment of addiction.
"An HIV/AIDS report by advocacy organizations in Uganda indicates that new transmissions are on the rise amidst troubling trends of increasing prevalence and incidence," Uganda's New Vision reports.
› Verified 3 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Researchers at Lund University have unexpectedly discovered that an old cancer drug can be used to prevent rejection of transplanted tissue. The researchers now have high hopes that their discovery could lead to new treatments for both transplant patients and patients with autoimmune diseases.
A group of researchers at the Institute for Research in Immunology and Cancer (IRIC) of Université de Montréal discovered a promising new approach to treating leukemia by disarming a gene that is responsible for tumor progression.
A new and comprehensive study by investigators at the Celiac Disease Center at Columbia University Medical Center has found that celiac patients are at no increased risk for dementia before or after their diagnosis of celiac disease.
The latest issue of Biological Psychiatry presents the results of three studies implicating metabotropic glutamate receptor 2 (mGluR2) as a new molecular target for the treatment of addiction.
"An HIV/AIDS report by advocacy organizations in Uganda indicates that new transmissions are on the rise amidst troubling trends of increasing prevalence and incidence," Uganda's New Vision reports.
› Verified 3 days ago
Aspirus Wausau Hospital Acute Care Hospital Location: 333 Pine Ridge Blvd, Wausau, Wisconsin 54401 Phone: (715) 847-2121 | |
North Central Health Care Psychiatric Hospital Location: 1100 Lakeview Dr, Wausau, Wisconsin 54403 Phone: (715) 848-4600 |